Skip to main content

Discussing Gastric Electrical Stimulation with patients

(0:01:42)

Dr. Joseph Sujka, Assistant Professor of GI Surgery at the University of South Florida College of Medicine and an implanter of the Enterra® Therapy System since 2022, shares how he discusses Enterra Therapy as a treatment option for patients with gastroparesis—offering a practical, real-world approach to patient conversations.

Watch video

Joseph Sujka, MD, PhD

Associate Professor of GI Surgery
University of South Florida

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?